Controversy Surrounding Semaglutide in Weight Loss Drug

A controversial study has linked the weight loss drug semaglutide, found in Ozempic, to suicidal ideation. Some research suggests a connection, while others are skeptical. The drug induces feelings of fullness and weight loss but may have adverse psychiatric effects.

Effects of Weight Loss Jabs on Behavior

Weight loss jabs like Ozempic and Wegovy may trigger reckless behavior, including risky sex, compulsive gambling, and rash major life decisions, due to changes in brain dopamine levels. Patients should be warned about potential impulse-control disorder before starting the treatment.

New Weight Loss Pill Amycretin by Novo Nordisk

A new pill called Amycretin by Novo Nordisk is showing promising results in weight loss, outperforming the weight loss injections like Wegovy. The pill mimics hormones that make you feel full and stop overeating. The pharmaceutical firm is experiencing a surge in value due to these results. Trials for Amycretin are ongoing.